Home / Resource Library / RESPONSE-ADAPTED TREATMENT WITH MOSUNETUZUMAB WITH OR WITHOUT OBINUTUZUMAB AND POLATUZUMAB VEDOTIN IN TREATMENT NAIVE FOLLICULAR AND MARGINAL ZONE LYMPHOMA: INTERIM RESULTS AND PHASED-SEQ MRD ANALYSIS
RESPONSE-ADAPTED TREATMENT WITH MOSUNETUZUMAB WITH OR WITHOUT OBINUTUZUMAB AND POLATUZUMAB VEDOTIN IN TREATMENT NAIVE FOLLICULAR AND MARGINAL ZONE LYMPHOMA: INTERIM RESULTS AND PHASED-SEQ MRD ANALYSIS